These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 9528829
1. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice. Misaki M, Ueyama Y, Tsukamoto G, Matsumura T. Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829 [Abstract] [Full Text] [Related]
3. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice. Ishikawa M, Okada Y, Satake-Ishikawa R, Kakitani M, Kawagishi M, Matsuki S, Kusaka M, Asano K. Gen Pharmacol; 1994 May; 25(3):533-7. PubMed ID: 7523237 [Abstract] [Full Text] [Related]
5. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor. Tamura M, Nomura H, Ono M, Bessho M, Hirashima K. Leukemia; 1991 Dec; 5(12):1043-9. PubMed ID: 1723131 [Abstract] [Full Text] [Related]
6. Effect of recombinant human granulocyte colony-stimulating factor on variations of morphologically identifiable bone marrow cells in myelosuppressed mice. Kabaya K, Kusaka M, Seki M. In Vivo; 1994 Dec; 8(6):1033-9. PubMed ID: 7539636 [Abstract] [Full Text] [Related]
7. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance. Hamood M, Bluche PF, De Vroey C, Corazza F, Bujan W, Fondu P. Mycoses; 1994 Dec; 37(3-4):93-9. PubMed ID: 7531290 [Abstract] [Full Text] [Related]
8. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy. Kabaya K, Obuchi M, Watanabe M, Kusaka M, Seki M. Oncol Res; 1995 Dec; 7(3-4):165-71. PubMed ID: 8555650 [Abstract] [Full Text] [Related]
10. Treatment of chemotherapy-induced neutropenia in children with subcutaneously administered recombinant human granulocyte colony-stimulating factor. Okamura J, Yokoyama M, Tsukimoto I, Komiyama A, Sakurai M, Imashuku S, Miyazaki S, Ueda K, Hanawa Y, Takaku F. Pediatr Hematol Oncol; 1992 Dec; 9(3):199-207. PubMed ID: 1381941 [Abstract] [Full Text] [Related]
11. The influence of recombinant human granulocyte colony-stimulating factor on granulopoiesis in mice recovering from cyclophosphamide treatment. Barrios L, Poletti OH, Agustini MI. Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):275-80. PubMed ID: 11031727 [Abstract] [Full Text] [Related]
12. [Effects of HS 6101 and rhG-CSF on Hematopoiesis Recovery of ICR Mice Injured by Cyclophosphamide]. Xiong GL, Shen X, Liu XL, Yang M, Dai CL, Liu XY, Xing S, Yu ZY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1716-20. PubMed ID: 26708899 [Abstract] [Full Text] [Related]
13. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Drize N, Chertkov J, Zander A. Exp Hematol; 1995 Oct; 23(11):1180-6. PubMed ID: 7556528 [Abstract] [Full Text] [Related]
16. Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide. Wakiyama H, Tsuru S, Hata N, Shinomiya M, Shinomiya N, Noritake M, Umezawa Y, Rokutanda M. Clin Exp Immunol; 1993 May; 92(2):218-24. PubMed ID: 7683585 [Abstract] [Full Text] [Related]